Measurement of Tumor Vascular Damage in Mice with 99mTc-MIBI Following Photodynamic Therapy

Photochemistry and Photobiology

Volumn 64, Issue 4, 1996, Pages 702-706

  Brasseur, Nicole ^a   Lewis, Karina ^a   Rousseau, Jacques ^a   Van Lier, Johan E ^a,b  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; EXPERIMENTAL NEOPLASM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PERFUSION; PHOTOCHEMOTHERAPY; VASCULARIZATION;

ANIMALS; CONTRAST MEDIA; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PERFUSION; PHOTOCHEMOTHERAPY; TECHNETIUM TC 99M SESTAMIBI;

ANIMALIA;

EID: 0030266431     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-1097.1996.tb03127.x     Document Type: Article

References (26)

1. Rosenthal, D. I. and E. Glatstein (1994) Clinical applications of photodynamic therapy. Ann. Med. 26, 405-409.
2. van Hillegersberg, R., W. J. Kort and J. H. Wilson (1994) Current status of photodynamic therapy in oncology. Drugs 48, 510-527.
3. Spalding B. J. (1993) QLT wins approval of photodynamic therapy. Biotechnology 11, 648-649.
4. Dougherty, T. J. (1993) Photodynamic therapy. Yearly review. Photochem. Photobiol. 58, 895-900.
5. Henderson, B. W. and T. J. Dougherty (1993) How does photodynamic therapy work? Photochem. Photobiol. 55, 145-147.
6. Margaron, P., P. Madarnas, R. Quellet and J. E. van Lier (1994) Early pathological alterations induced by photodynamic therapy with aluminium sulfophthalocyanines and photofrin. J. Chim. Phys. 91, 1219-1222.
7. Margaron, P., P. Madarnas, R. Quellet and J. E. van Lier (1996) Biological activities of phthalocyanines XVII. Histopathologic evidence for different mechanisms of EMT-6 tumor necrosis induced by photodynamic therapy with disulfonated aluminum phthalocyanine or Photofrin. Anticancer Res. 16, 613-620.
8. Chan, W.-S., N. Brasseur, C. LaMadeleine and J. E. van Lier (1996) Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or Photofrin: tumor cell survival and blood flow. Anticancer Res. (In press)
9. Fingar, V. H. (1993) Mechanisms leading to vessel damage after photodynamic therapy. Photochem. Photobiol. Suppl. 57, 18S-19S. [Abstract]
10. Penning, L. C. and T. M. Dubbelman (1994) Fundamentals of photodynamic therapy: cellular and biochemical aspects. Review paper. Anti-Cancer Drugs 5, 139-146.
11. Selman, S. H., M. Kreimer-Birnbaum, J. E. Klaunig, P. J. Goldblatt, R. W. Keck and S. L. Britton (1984) Blood flow in transplantable bladder tumors treated with hematoporphyrin derivative and light. Cancer Res. 44, 1924-1927.
12. Selman, S. H., A. J. Milligan, M. Kreimer-Birnbaum, R. W. Keck, P. J. Goldblatt and S. L. Britton (1985) Hematoporphyrin derivative photochemotherapy of experimental bladder tumors. J. Urol. 133, 330-333.
13. 99technetium HMPAO scintigraphy. Br. J. Cancer 65, 491-497.
14. Moore, R. B., J. D. Chapman, J. R. Mercer, R. H. Mannan, L. I. Wiebe, A. J. McEwan and M. S. McPhee (1993) Measurement of PDT-induced hypoxia in Dunning prostate tumors by iodine123-iodoazomycin arabinoside. J. Nucl. Med. 34, 405-413.
15. Roberts, D. J. H., F. Cairnduff, I. Driver, B. Dixon and S. B. Brown (1994) Tumor vascular shutdown following photodynamic therapy based on polyhaematoporphyrin or 5-aminolaevulinic acid. Int. J. Oncol. 5, 763-768.
16. van Geel, I. P. J., H. Oppelaar, Y. G. Oussoren and F. A. Stewart (1994) Changes in perfusion of mouse tumors after photodynamic therapy. Int. J. Cancer 56, 224-228.
17. van Geel, I. P. J., H. Oppelaar, Y. G. Oussoren, J. J. Schuitmaker and F. A. Stewart (1995) Mechanisms for optimising photodynamic therapy-second generation photosensitizers in combination with mitomycin C. Br. J. Cancer 72, 344-350.
18. Benstead, K. and J. V. Moore (1988) The effect of fractionation of light treatment on necrosis and vascular function of normal skin following photodynamic therapy. Br. J. Cancer 58, 301-305.
19. Moore, J. V., C. M. L. West and A. K. Haylett (1992) Vascular function and tissue injury in murine skin following hyperthermia and photodynamic therapy, alone and in combination. Br. J. Cancer 66, 1037-1043.
20. 99mTc myocardial perfusion imaging. Rev. Curr. Opin. Radiol. 3, 810-816.
21. Brasseur, N., H. Ali, R. Langlois, R. Wagner, J. R. Rousseau and J. E. van Lier (1987) Biological activities of phthalocyanines V. Photodynamic therapy of EMT-6 mammary tumors in mice with sulfonated phthalocyanines. Photochem. Pholobiol 45, 581-586.
22. 99mTc Sestamibi in tumor imaging. In Nuclear Medicine Annual (Edited by L. M. Freeman), pp. 181-235. Raven Press, New York.
23. 201T1 by a 9L gliosarcoma brain tumor model in rats. 1 Nucl. Med. Biol, 20, 773-776.
24. Lying, H., A. Skretting and E. K. Rofstad (1992) Blood flow in six human melanoma xenograft lines with different growth characteristics. Cancer Res. 32, 584-592.
25. Evensen, J. F. and J. Moan (1987) A test of different photosensitizers for photodynamic treatment of cancer in a murine tumor model. Photochem. Photobiol. 46, 859-865.
26. 99mTc-MIBI in rabbits bearing vx-2 cancer. Jn. J. Nucl. Med. 32, 199-203.